Teprotumumab-Related Adverse Events in Thyroid Eye Disease

医学 不利影响 甲状腺疾病 眼病 甲状腺 验光服务 眼科 内科学
作者
Shreya Shah,Linus Amarikwa,Connie Martin Sears,Kevin D. Clauss,Raneem D. Rajjoub,Julia Y. Kang,Madhura A. Tamhankar,César Augusto Briceño,Andrew R. Harrison,Chrysoula Dosiou,Kimberly Peele Cockerham,Sara Tullis Wester,Raymond S. Douglas,Andrea L. Kossler
出处
期刊:Ophthalmology [Elsevier BV]
卷期号:131 (4): 458-467 被引量:46
标识
DOI:10.1016/j.ophtha.2023.10.018
摘要

Purpose

To assess the duration, incidence, reversibility, and severity of adverse events (AEs) in patients with thyroid eye disease (TED) treated with teprotumumab.

Design

Multicenter, retrospective, observational cohort study.

Participants

Patients with TED of all stages and activity levels treated with at least 4 infusions of teprotumumab.

Methods

Patients were treated with teprotumumab between February 2020 and October 2022 at 6 tertiary centers. Adverse event metrics were recorded at each visit.

Main Outcome Measures

The primary outcomes measure was AE incidence and onset. Secondary outcome measures included AE severity, AE reversibility, AE duration, proptosis response, clinical activity score (CAS) reduction, and Gorman diplopia score improvement.

Results

The study evaluated 131 patients. Proptosis improved by 2 mm or more in 77% of patients (101/131), with average proptosis improvement of 3.0 ± 2.1 mm and average CAS reduction of 3.2 points. Gorman diplopia score improved by at least 1 point for 50% of patients (36/72) with baseline diplopia. Adverse events occurred in 81.7% of patients (107/131). Patients experienced a median of 4 AEs. Most AEs were mild (74.0% [97/131]), 28.2% (37/131) were moderate, and 8.4% (11/131) were severe. Mean interval AE onset was 7.9 weeks after the first infusion. Mean resolved AE duration was 17.6 weeks. Forty-six percent of patients (60/131) demonstrated at least 1 persistent AE at last follow-up. Mean follow-up was 70.2 ± 38.5 weeks after the first infusion. The most common type of AEs was musculoskeletal (58.0% [76/131]), followed by gastrointestinal (38.2% [50/131]), skin (38.2% [50/131]), ear and labyrinth (30.5% [40/131]), nervous system (20.6% [27/131]), metabolic (15.3% [20/131]), and reproductive system (12.2% [16/131]). Sixteen patients (12.2%) discontinued therapy because of AEs, including hearing loss (n = 4), inflammatory bowel disease flare (n = 2), hyperglycemia (n = 1), muscle spasms (n = 1), and multiple AEs (n = 8).

Conclusions

Adverse events are commonly reported while receiving teprotumumab treatment. Most are mild and reversible; however, serious AEs can occur and may warrant treatment cessation. Treating physicians should inform patients about AE risk, properly screen patients before treatment, monitor patients closely throughout therapy, and understand how to manage AEs should they develop.

Financial Disclosure(s)

Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
仁仁仁完成签到,获得积分10
2秒前
灯座完成签到,获得积分10
4秒前
u雨发布了新的文献求助10
5秒前
Voiceless的应助被Bin_Liu采纳,获得10
8秒前
不吃压力就是干完成签到 ,获得积分10
8秒前
Lingeek完成签到,获得积分10
13秒前
霸气芫完成签到 ,获得积分10
17秒前
17秒前
betty2009完成签到,获得积分10
18秒前
饱满千兰完成签到,获得积分10
19秒前
科研通AI6.3的应助被u雨采纳,获得10
23秒前
王kk完成签到 ,获得积分10
24秒前
哈哈哈完成签到 ,获得积分10
26秒前
邓代容完成签到 ,获得积分0
31秒前
奋斗诗云完成签到 ,获得积分10
33秒前
irisyan完成签到 ,获得积分10
35秒前
白云完成签到 ,获得积分10
36秒前
难过的研究牲完成签到 ,获得积分10
37秒前
大耳朵图图完成签到 ,获得积分10
38秒前
孤狼完成签到 ,获得积分10
42秒前
子良完成签到 ,获得积分10
42秒前
xinxin完成签到 ,获得积分10
43秒前
黑白完成签到 ,获得积分10
43秒前
一诺相许完成签到,获得积分10
45秒前
领导范儿的应助被文文采纳,获得10
47秒前
xh完成签到,获得积分10
48秒前
QwQ完成签到 ,获得积分10
49秒前
高兴的灰狼完成签到,获得积分20
49秒前
科研猫完成签到,获得积分10
50秒前
nanting完成签到 ,获得积分10
53秒前
momo完成签到,获得积分10
56秒前
求知小生完成签到 ,获得积分10
58秒前
Ava完成签到,获得积分10
59秒前
1分钟前
冷傲的婷冉完成签到,获得积分10
1分钟前
Ayun完成签到,获得积分10
1分钟前
1分钟前
Ayun发布了新的文献求助10
1分钟前
爱听歌的香萱完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180068
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808724
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012